Cargando…
Liver Directed Therapy for Renal Cell Carcinoma
Background: Metastatic renal cell carcinoma (RCC) to the liver portrays a poor prognosis and liver directed therapy remains controversial. We aimed to determine potential selection criteria for patients who might benefit from this strategy. Materials and Methods: We evaluated 247 consecutive patient...
Autores principales: | Langan, Russell C., Ripley, R. Taylor, Davis, Jeremy L., Prieto, Peter A., Datrice, Nicole, Steinberg, Seth M., Bratslavsky, Gennady, Rudloff, Udo, Kammula, Udai S., Stojadinovic, Alexander, Avital, Itzhak |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Ivyspring International Publisher
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3342526/ https://www.ncbi.nlm.nih.gov/pubmed/22558019 http://dx.doi.org/10.7150/jca.4456 |
Ejemplares similares
-
Regional Chemotherapy in Locally Advanced Pancreatic Cancer: RECLAP Trial
por: Davis, Jeremy L, et al.
Publicado: (2011) -
Establishment of Human Ultra-Low Passage Colorectal Cancer Cell Lines Using Spheroids from Fresh Surgical Specimens Suitable for In Vitro and In Vivo Studies
por: Ray, Satyajit, et al.
Publicado: (2012) -
A Pilot Study Assessing the Potential Role of non-CD133 Colorectal Cancer Stem Cells as Biomarkers
por: Langan, Russell C., et al.
Publicado: (2012) -
Prospective randomized trial evaluating mandatory second look surgery with HIPEC and CRS vs. standard of care in patients at high risk of developing colorectal peritoneal metastases
por: Ripley, Robert T, et al.
Publicado: (2010) -
Colorectal Cancer Biomarkers and the Potential Role of Cancer Stem Cells
por: Langan, Russell C., et al.
Publicado: (2013)